Lehrstuhl für Haut- und Geschlechtskrankheiten

The distribution of C-type lectin receptors in the Dendritic cell membrane (2017) Lühr J, Eissing N, Heidkamp GF, Lehmann CHK, Heger L, Dudziak D Conference contribution Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without prior System Therapy with regard to compatibility-related Therapeutic Adherence: Safety Results of the PRIME Study (2017) Mrowietz U, Augustin M, Thaci D, Reich K, Kneidl J, Hentschke C, Simang M, et al. Conference contribution Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis with without previous Systemic Therapy for Improvement of Nail Symptoms: NAPSI Results PRIME Study (2017) Thaci D, Reich K, Mrowietz U, Augustin M, Kneidl J, Hentschke C, Simang M, et al. Conference contribution The simultaneous siRNA-mediated downregulation of inhibitory receptors to improve CAR-T cell immunotherapy of melanoma (2017) Simon B, Harrer D, Weide B, Schuler G, Schuler-Thurner B, Dörrie J, Schaft N, Uslu U Conference contribution Psoriasis - Occurrence and Reality: Disease of the Psoriasis Group (2017) Leupolz S, Sticherling M Conference contribution Psoriasis vulgaris as Manifestation of Immune Reconstitution in Patients with Hepatitis C under Treatment with Ledipasvir/Sofosbuvir (2017) Heppt F, Sticherling M Conference contribution Lungs Ailment - other Comorbidity of the Psoriasis? (2017) Moreira A, Sticherling M Conference contribution PASI <= 2 corresponds to PASI 90, irrespective of baseline severity: A post-hoc analysis of the PRIME-study (2017) Reich K, Sieder C, Bachhuber T, Melzer N, Sticherling M Conference contribution Psoriasis in children: a single-centre analysis (2017) Heppt F, Raap J, Sticherling M Conference contribution RNA-transfection of gamma/delta T cells with a chimeric antigen receptor or an alpha/ss T-cell receptor: a safer alternative to genetically engineered alpha/ss T cells for the immunotherapy of melanoma (2017) Harrer D, Simon B, Fujii SI, Kanako S, Uslu U, Schuler G, Gerer KF, et al. Conference contribution